BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32274339)

  • 1. A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01).
    Yin X; Han G; Zhang H; Wang M; Zhang W; Gao Y; Zhong M; Wang X; Zhong X; Shen G; Yang C; Liu H; Liu Z; Chan PL; Bulterys M; Cui F; Zhuang H; Liu Z; Hou J
    J Clin Transl Hepatol; 2020 Mar; 8(1):1-8. PubMed ID: 32274339
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus.
    Pan CQ; Duan ZP; Bhamidimarri KR; Zou HB; Liang XF; Li J; Tong MJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):452-9. PubMed ID: 22079509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mother-to-child transmission of hepatitis B virus after amniocentesis: A retrospective matched cohort study.
    Han Z; Zhang Y; Bai X; Yin Y; Xu C; Hou H
    Prenat Diagn; 2019 May; 39(6):431-440. PubMed ID: 30916399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
    N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
    Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
    Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
    Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
    Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
    Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
    Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
    Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
    Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Perinatal Hepatitis B Virus Transmission.
    Nelson NP; Jamieson DJ; Murphy TV
    J Pediatric Infect Dis Soc; 2014 Sep; 3 Suppl 1(Suppl 1):S7-S12. PubMed ID: 25232477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
    Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
    Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them.
    Seo KI; Bae SH; Sung PS; Park CH; Lee HL; Kim HY; Kim HJ; Jang BH; Jang JW; Yoon SK; Choi JY; Park IY; Lee J; Lee HS; Kim SJ; Kwon JH; Chang UI; Kim CW; Jo SH; Lee Y; Tekle F; Kim JH
    Clin Mol Hepatol; 2018 Dec; 24(4):374-383. PubMed ID: 29940720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus.
    Zhao M; Zou H; Chen Y; Zheng S; Duan Z
    J Viral Hepat; 2019 Sep; 26(9):1059-1065. PubMed ID: 31087455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates.
    Peng TT; Cai QE; Yang M; Chen SP; Chen F; Wang M; Peng L; Wong G; Shen CG; Cheng WB; Liu SY; Peng YB; Peng JH; Chen CM; Yang LQ; Tang YM; Xu ZX; Liu YX
    Arch Virol; 2019 May; 164(5):1335-1341. PubMed ID: 30848390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
    Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
    Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.